Tumor necrosis factor-alpha promotes survival in methotrexate-exposed macrophages by an NF-kappaB-dependent pathway.
about
Combination with methotrexate and cyclophosphamide attenuated maturation of dendritic cells: inducing Treg skewing and Th17 suppression in vivo.Prospects of apoptotic cell-based therapies for transplantation and inflammatory diseases.Involvement of calmodulin and calmodulin kinase II in tumor necrosis factor alpha-induced survival of bone marrow derived macrophages.Expression of 4-1BB and its ligand on blasts correlates with prognosis of patients with AML.Alteration of inflammatory response by shock wave therapy leads to reduced calcification of decellularized aortic xenografts in mice†.
P2860
Tumor necrosis factor-alpha promotes survival in methotrexate-exposed macrophages by an NF-kappaB-dependent pathway.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Tumor necrosis factor-alpha pr ...... n NF-kappaB-dependent pathway.
@ast
Tumor necrosis factor-alpha pr ...... n NF-kappaB-dependent pathway.
@en
type
label
Tumor necrosis factor-alpha pr ...... n NF-kappaB-dependent pathway.
@ast
Tumor necrosis factor-alpha pr ...... n NF-kappaB-dependent pathway.
@en
prefLabel
Tumor necrosis factor-alpha pr ...... n NF-kappaB-dependent pathway.
@ast
Tumor necrosis factor-alpha pr ...... n NF-kappaB-dependent pathway.
@en
P2093
P2860
P356
P1476
Tumor necrosis factor-alpha pr ...... n NF-kappaB-dependent pathway.
@en
P2093
David A Joyce
James H Steer
Susan Z Y Lo
P2860
P2888
P356
10.1186/AR3248
P577
2011-02-15T00:00:00Z
P5875
P6179
1011405392